|
| Nfkb1/p50 and mammalian aging |
|
https://doi.org/10.18632/oncotarget.3405
Bakhtiar Yamini
|
| 3471-3472 |
|
| Nonmutational epigenomic structural variation in the transcriptome of cancer cells |
|
https://doi.org/10.18632/oncotarget.3406
E. Aubrey Thompson
|
| 3473-3474 |
|
| Prelamin A and Oct1: a puzzle of aging |
|
https://doi.org/10.18632/oncotarget.3422
Arantza Infante, and Clara I. RodrÃguez
|
| 3475-3476 |
|
| Dßhydroxybutyrate: an antiaging ketone body |
|
https://doi.org/10.18632/oncotarget.3423
Clare Edwards, Neil Copes, and Patrick C. Bradshaw
|
| 3477-3478 |
|
| PD1 pathway inhibitors: The next generation of immunotherapy for advanced melanoma |
|
https://doi.org/10.18632/oncotarget.2980
Jason J. Luke, and Patrick A. Ott
|
| 3479-3492 |
|
| The multiple cellular functions of the oncoprotein Golgi phosphoprotein 3 |
|
https://doi.org/10.18632/oncotarget.3051
Stefano Sechi, Anna Frappaolo, Giorgio Belloni, Gianni Colotti, and Maria Grazia Giansanti
|
| 3493-3506 |
|
| Roles of cMet and RON kinases in tumor progression and their potential as therapeutic targets |
|
https://doi.org/10.18632/oncotarget.3420
Katherine Chang, Anand Karnad, Shujie Zhao, and James W. Freeman
|
| 3507-3518 |
|
| Bcl2 family proteins in breast development and cancer: could Mcl1 targeting overcome therapeutic resistance |
|
https://doi.org/10.18632/oncotarget.2792
Michelle M. Williams, and Rebecca S. Cook
|
| 3519-3530 |
|
| Potential crosstalk between cofilin1 and EGFR pathways in cisplatin resistance of nonsmallcell lung cancer |
|
https://doi.org/10.18632/oncotarget.3471
Carolina Beatriz Müller, Marco Antônio De Bastiani, Matheus Becker, Fernanda Stapenhorst França, Mariane Araujo Branco, Mauro Antônio Alves Castro, and Fábio Klamt
|
| 3531-3539 |
|
| 14q32encoded microRNAs mediate an oligometastatic phenotype |
|
https://doi.org/10.18632/oncotarget.2920
Abhineet Uppal, Sean C. Wightman, Stephen Mallon, Go Oshima, Sean P. Pitroda, Qingbei Zhang, Xiaona Huang, Thomas E. Darga, Lei Huang, Jorge Andrade, Huiping Liu, Mark K. Ferguson, Geoffrey L. Greene, Mitchell C. Posner, Samuel Hellman, Nikolai N. Khodarev, and Ralph R. Weichselbaum
|
| 3540-3552 |
|
| Graphene oxide selectively targets cancer stem cells across multiple tumor types: Implications for nontoxic cancer treatment via “differentiationbased nanotherapy†|
|
https://doi.org/10.18632/oncotarget.3348
Marco Fiorillo, Andrea F. Verre, Maria Iliut, Maria Peiris-Pagés, Bela Ozsvari, Ricardo Gandara, Anna Rita Cappello, Federica Sotgia, Aravind Vijayaraghavan, and Michael P. Lisanti
|
| 3553-3562 |
|
| p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia |
|
https://doi.org/10.18632/oncotarget.2969
Alper Yetil, Benedict Anchang, Arvin M. Gouw, Stacey J. Adam, Tahera Zabuawala, Ramya Parameswaran, Jan van Riggelen, Sylvia Plevritis, and Dean W. Felsher
|
| 3563-3577 |
|
| Trafficking protein particle complex 6A delta TRAPPC6AΔ is an extracellular plaqueforming protein in the brain |
|
https://doi.org/10.18632/oncotarget.2876
Jean-Yun Chang, Ming-Hui Lee, Sing-Ru Lin, Li-Yi Yang, Sunny H. Sun, Chun-I Sze, Qunying Hong, Yee-Shin Lin, Ying-Tsen Chou, Li-Jin Hsu, Ming-Shiou Jan, Cheng-Xin Gong, and Nan-Shan Chang
|
| 3578-3589 |
|
| Plasmid DNAcoding p62 as a bone effective antiinflammatory/anabolic agent |
|
https://doi.org/10.18632/oncotarget.2884
Maria Giovanna Sabbieti, Dimitrios Agas, Melania Capitani, Luigi Marchetti, Antonio Concetti, Cecilia Vullo, Giuseppe Catone, Vladimir Gabai, Victor Shifrin, Michael Y. Sherman, Alexander Shneider, and Franco M. Venanzi
|
| 3590-3599 |
|
| Noncoding genomic regions possessing enhancer and silencer potential are associated with healthy aging and exceptional survival |
|
https://doi.org/10.18632/oncotarget.2877
Sangkyu Kim, David A. Welsh, Leann Myers, Katie E. Cherry, Jennifer Wyckoff, and S. Michal Jazwinski
|
| 3600-3612 |
|
| The function of CUX1 in oxidative DNA damage repair is needed to prevent premature senescence of mouse embryo fibroblasts |
|
https://doi.org/10.18632/oncotarget.2919
Zubaidah M. Ramdzan, Ranjana Pal, Simran Kaur, Lam Leduy, Ginette Bérubé, Sayeh Davoudi, Charles Vadnais, and Alain Nepveu
|
| 3613-3626 |
|
| DNA methylome and transcriptome sequencing in human ovarian granulosa cells links agerelated changes in gene expression to gene body methylation and 3’end GC density |
|
https://doi.org/10.18632/oncotarget.2875
Bo Yu MD, Valya R. Russanova, Silvia Gravina, Stephen Hartley, James C. Mullikin, Alice Ignezweski, James Graham, James H. Segars, Alan H. DeCherney, and Bruce H. Howard
|
| 3627-3643 |
|
| Autophagy through 4EBP1 and AMPK regulates oxidative stressinduced premature senescence in auditory cells |
|
https://doi.org/10.18632/oncotarget.2874
Nana Akagi Tsuchihashi, Ken Hayashi, Katsuaki Dan, Fumiyuki Goto, Yasuyuki Nomura, Masato Fujioka, Sho Kanzaki, Shizuo Komune, and Kaoru Ogawa
|
| 3644-3655 |
|
| Plasmin releases the antitumor peptide from the NC1 domain of collagen XIX |
|
https://doi.org/10.18632/oncotarget.2849
Jean-Baptiste Oudart, Sylvie Brassart-Pasco, Alexia Vautrin, Christelle Sellier, Carine Machado, Aurelie Dupont-Deshorgue, Bertrand Brassart, Stéphanie Baud, Manuel Dauchez, Jean-Claude Monboisse, Dominique Harakat, François-Xavier Maquart, and Laurent Ramont
|
| 3656-3668 |
|
| Notch3 functions as a regulator of cell selfrenewal by interacting with the βcatenin pathway in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.2898
Qingyu Zhang, Caijie Lu, Tao Fang, Yongcun Wang, Wenhua Hu, Jie Qiao, Bin Liu, Jie Liu, Nianping Chen, Mingyi Li, and Runzhi Zhu
|
| 3669-3679 |
|
| PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neovascularisation |
|
https://doi.org/10.18632/oncotarget.2918
Christine Levesque, Frédéric Couture, Anna Kwiatkowska, Roxane Desjardins, Brigitte Guérin, Witold A. Neugebauer, and Robert Day
|
| 3680-3693 |
|
| Interleukin27 reeducates intratumoral myeloid cells and downregulates stemness genes in nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.2797
Irma Airoldi, Maria Grazia Tupone, Silvia Esposito, Marco Vincenzo Russo, Giulia Barbarito, Giuseppe Cipollone, and Emma Di Carlo
|
| 3694-3708 |
|
| Role of microRNA221 in regulating normal mammary epithelial hierarchy and breast cancer stemlike cells |
|
https://doi.org/10.18632/oncotarget.2888
Jia Ke, Zhiju Zhao, Su-Hyung Hong, Shoumin Bai, Zhen He, Fayaz Malik, Jiahui Xu, Lei Zhou, Weilong Chen, Rachel Martin-Trevino, Xiaojian Wu, Ping Lan, Yongju Yi, Christophe Ginestier, Ingrid Ibarra, Li Shang, Sean McDermott, Tahra Luther, Shawn G. Clouthier, Max S. Wicha, and Suling Liu
|
| 3709-3721 |
|
| Oncoprotein mdig contributes to silicainduced pulmonary fibrosis by altering balance between Th17 and Treg T cells |
|
https://doi.org/10.18632/oncotarget.2914
Chitra Thakur, Michael Wolfarth, Jiaying Sun, Yadong Zhang, Yongju Lu, Lori Battelli, Dale W. Porter, and Fei Chen
|
| 3722-3736 |
|
| Zfra activates memory Hyal2+ CD3 CD19 spleen cells to block cancer growth stemness and metastasis in vivo |
|
https://doi.org/10.18632/oncotarget.2895
Ming-Hui Lee, Wan-Pei Su, Wan-Jen Wang, Sing-Ru Lin, Chen-Yu Lu, Yu-An Chen, Jean-Yun Chang, Shenq-Shyang Huang, Pei-Yi Chou, Siou-Ru Ye, Szu-Jung Chen, Huan He, Ting-Hsiu Liu, Ying-Tsen Chou, Li-Jin Hsu, Feng-Jie Lai, Shean-Jen Chen, Hoong-Chien Lee, David Kakhniashvili, Steven R. Goodman, and Nan-Shan Chang
|
| 3737-3751 |
|
| CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelialmesenchymal transition in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.2915
Xin Zheng, Tao Song, Changwei Dou, Yuli Jia, and Qingguang Liu
|
| 3752-3769 |
|
| MicroRNA10b inhibition reduces E2F1mediated transcription and miR15/16 activity in glioblastoma |
|
https://doi.org/10.18632/oncotarget.3009
Nadiya M. Teplyuk, Erik J. Uhlmann, Andus Hon-Kit Wong, Priya Karmali, Meenakshi Basu, Galina Gabriely, Anant Jain, Yang Wang, E. Antonio Chiocca, Robert Stephens, Eric Marcusson, Ming Yi, and Anna M. Krichevsky
|
| 3770-3783 |
|
| Protease nexin 1 induces apoptosis of prostate tumor cells through inhibition of Xchromosomelinked inhibitor of apoptosis protein |
|
https://doi.org/10.18632/oncotarget.2921
Chad M. McKee, Yunchuan Ding, Jianfeng Zhou, Chunrui Li, Liang Huang, Xiangke Xin, Jing He, Joshua E. Allen, Wafik S. El-Deiry, Yunhong Cao, Ruth J. Muschel, and Danmei Xu
|
| 3784-3796 |
|
| Vacuolar ATPase 'a2' isoform exhibits distinct cell surface accumulation and modulates matrix metalloproteinase activity in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.2902
Arpita Kulshrestha, Gajendra K. Katara, Safaa Ibrahim, Sahithi Pamarthy, Mukesh K. Jaiswal, Alice Gilman Sachs, and Kenneth D. Beaman
|
| 3797-3810 |
|
| EPI001 is a selective peroxisome proliferatoractivated receptorgamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancer |
|
https://doi.org/10.18632/oncotarget.2924
Lucas J. Brand, Margaret E. Olson, Preethi Ravindranathan, Hong Guo, Aaron M. Kempema, Timothy E. Andrews, Xiaoli Chen, Ganesh V. Raj, Daniel A. Harki, and Scott M. Dehm
|
| 3811-3824 |
|
| NFkB signaling mediates acquired resistance after PARP inhibition |
|
https://doi.org/10.18632/oncotarget.2868
Yuko Nakagawa, Anna S Sedukhina, Naoki Okamoto, Satoi Nagasawa, Nao Suzuki, Tomohiko Ohta, Hiroyoshi Hattori, Marta Roche-Molina, Ana J Narváez, Anand D Jeyasekharan, Juan A Bernal, and Ko Sato
|
| 3825-3839 |
|
| MicroRNA153 promotes Wnt/βcatenin activation in hepatocellular carcinoma through suppression of WWOX |
|
https://doi.org/10.18632/oncotarget.2927
Hong-Wei Hua, Feng Jiang, Qian Huang, Zhijun Liao, and Gang Ding
|
| 3840-3847 |
|
| NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNAPKcs inhibitor |
|
https://doi.org/10.18632/oncotarget.2975
Lan Yu, Zeng-Fu Shang, Feng-Ming Hsu, Zhang Zhang, Vasu Tumati, Yu-Fen Lin, Benjamin P. C. Chen, and Debabrata Saha
|
| 3848-3860 |
|
| Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells |
|
https://doi.org/10.18632/oncotarget.2869
Ping Song, Li Ye, Jiajun Fan, Yubin Li, Xian Zeng, Ziyu Wang, Shaofei Wang, Guoping Zhang, Ping Yang, Zhonglian Cao, and Dianwen Ju
|
| 3861-3873 |
|
| Shed syndecan2 enhances tumorigenic activities of colon cancer cells |
|
https://doi.org/10.18632/oncotarget.2885
Sojoong Choi, Youngsil Choi, Eunsung Jun, In-San Kim, Seong-Eun Kim, Sung-Ae Jung, and Eok-Soo Oh
|
| 3874-3886 |
|
| Inhibition of hedgehog signaling improves the anticarcinogenic effects of docetaxel in prostate cancer |
|
https://doi.org/10.18632/oncotarget.2932
Murielle Mimeault, Satyanarayana Rachagani, Sakthivel Muniyan, Parthasarathy Seshacharyulu, Sonny L. Johansson, Kaustubh Datta, Ming-Fong Lin, and Surinder K. Batra
|
| 3887-3903 |
|
| Downregulation of microRNA23a suppresses prostate cancer metastasis by targeting the PAK6LIMK1 signaling pathway |
|
https://doi.org/10.18632/oncotarget.2880
Songwang Cai, Ruihan Chen, Xiaojuan Li, Yi Cai, Zhiqiang Ye, Shigeng Li, Jun Li, Huaiqiu Huang, Shubin Peng, Jun Wang, Yiran Tao, Hongxing Huang, Xinglai Wen, Jianfeng Mo, Zhupeng Deng, Jian Wang, Yangfan Zhang, Xin Gao, and Xingqiao Wen
|
| 3904-3917 |
|
| Increase of miR199a5p by protoporphyrin IX a photocatalyzer directly inhibits E2F3 sensitizing mesenchymal tumor cells to anticancer agents |
|
https://doi.org/10.18632/oncotarget.2928
Jung Min Lee, Mi Jeong Heo, Chan Gyu Lee, Yoon Mee Yang, and Sang Geon Kim
|
| 3918-3931 |
|
| HeregulinHER3HER2 signaling promotes matrix metalloproteinasedependent bloodbrainbarrier transendothelial migration of human breast cancer cell lines |
|
https://doi.org/10.18632/oncotarget.2846
Majid Momeny, Jodi M. Saunus, Flavia Marturana, Amy E. McCart Reed, Debra Black, Gianluca Sala, Stefano Iacobelli, Jane D. Holland, Dihua Yu, Leonard Da Silva, Peter T. Simpson, Kum Kum Khanna, Georgia Chenevix-Trench, and Sunil R. Lakhani
|
| 3932-3946 |
|
| Identification of NDUFAF1 in mediating KRas induced mitochondrial dysfunction by a proteomic screening approach |
|
https://doi.org/10.18632/oncotarget.2968
Peng Wang, Ming Song, Zhao-lei Zeng, Chao-feng Zhu, Wen-hua Lu, Jing Yang, Ming-zhe Ma, A-min Huang, Yumin Hu, and Peng Huang
|
| 3947-3962 |
|
| Morphine promotes cancer stem cell properties contributing to chemoresistance in breast cancer |
|
https://doi.org/10.18632/oncotarget.2894
Dong-Ge Niu, Fei Peng, Wei Zhang, Zhong Guan, Hai-Dong Zhao, Jing-Lin Li, Kai-Li Wang, Ting-Ting Li, Yan Zhang, Fei-Meng Zheng, Fan Xu, Qian-Ni Han, Peng Gao, Qing-Ping Wen, and Quentin Liu
|
| 3963-3976 |
|
| Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy |
|
https://doi.org/10.18632/oncotarget.2897
Ilya V. Ulasov, Nameeta Shah, Natalya V. Kaverina, Hwahyang Lee, Biaoyang Lin, Andre Lieber, Zaira G. Kadagidze, Jae-Guen Yoon, Brett Schroeder, Parvinder Hothi, Dhimankrishna Ghosh, Anatoly Y. Baryshnikov, and Charles S. Cobbs
|
| 3977-3987 |
|
| miR34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/cMyc pathway |
|
https://doi.org/10.18632/oncotarget.2905
Xinsen Xu, Wei Chen, Runchen Miao, Yanyan Zhou, Zhixin Wang, Lingqiang Zhang, Yong Wan, Yafeng Dong, Kai Qu, and Chang Liu
|
| 3988-4004 |
|
| Cterminal domain of SMYD3 serves as a unique HSP90regulated motif in oncogenesis |
|
https://doi.org/10.18632/oncotarget.2970
Mark A. Brown, Kenneth Foreman, June Harriss, Chhaya Das, Li Zhu, Melissa Edwards, Salam Shaaban, and Haley Tucker
|
| 4005-4019 |
|
| Artesunate suppresses tumor growth and induces apoptosis through the modulation of multiple oncogenic cascades in a chronic myeloid leukemia xenograft mouse model |
|
https://doi.org/10.18632/oncotarget.3004
Chulwon Kim, Jong Hyun Lee, Sung-Hoon Kim, Gautam Sethi, and Kwang Seok Ahn
|
| 4020-4035 |
|
| Novel long noncoding RNAs are specific diagnostic and prognostic markers for prostate cancer |
|
https://doi.org/10.18632/oncotarget.2879
René Böttcher, A. Marije Hoogland, Natasja Dits, Esther I. Verhoef, Charlotte Kweldam, Piotr Waranecki, Chris H Bangma, Geert J.L.H. van Leenders, and Guido Jenster
|
| 4036-4050 |
|
| Adenovirus expressing dual cMetspecific shRNA exhibits potent antitumor effect through autophagic cell death accompanied by senescencelike phenotypes in glioblastoma cells |
|
https://doi.org/10.18632/oncotarget.3018
Jung-Sun Lee, Eonju Oh, Ji Young Yoo, Kyeong Sook Choi, Mi Jin Yoon, and Chae-Ok Yun
|
| 4051-4065 |
|
| miR106b5p targets tumor suppressor gene SETD2 to inactive its function in clear cell renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.2926
Wei Xiang, Jun He, Chao Huang, Lejun Chen, Dan Tao, Xinchao Wu, Miao Wang, Gang Luo, Xingyuan Xiao, Fuqing Zeng, and Guosong Jiang
|
| 4066-4079 |
|
| Cytoplasmic TRAF4 contributes to the activation of p70s6k signaling pathway in breast cancer |
|
https://doi.org/10.18632/oncotarget.2977
Hua-Yan Ren, Jian Wang, Fan Yang, Xiao-Li Zhang, Ai-Lian Wang, Li-Li Sun, Ke-Xin Diao, En-Hua Wang, and Xiao-Yi Mi
|
| 4080-4096 |
|
| Multilevelanalysis identify a cisexpression quantitative trait locus associated with risk of renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.3001
Xiang Shu, Mark P. Purdue, Yuanqing Ye, Christopher G. Wood, Meng Chen, Zhaoming Wang, Demetrius Albanes, Xia Pu, Maosheng Huang, Victoria L. Stevens, W. Ryan Diver, Susan M. Gapstur, Jarmo Virtamo, Wong-Ho Chow, Nizar M. Tannir, Colin P. Dinney, Nathaniel Rothman, Stephen J. Chanock, and Xifeng Wu
|
| 4097-4109 |
|
| p22phox confers resistance to cisplatin by blocking its entry into the nucleus |
|
https://doi.org/10.18632/oncotarget.2893
Chih-Chang Hung, Chen-Yu Chien, Wei-Fan Chiang, Chang-Shen Lin, Tzyh-Chyuan Hour, Hau-Ren Chen, Ling-Feng Wang, Jenq-Yuh Ko, Chi-Hua Chang, and Jeff Yi-Fu Chen
|
| 4110-4125 |
|
| A novel orally active watersoluble Inhibitor of human glutathione transferase exerts a potent and selective antitumor activity against human melanoma xenografts |
|
https://doi.org/10.18632/oncotarget.2798
Anastasia De Luca, Dante Rotili, Debora Carpanese, Alessia Lenoci, Laura Calderan, Manuel Scimeca, Antonello Mai, Elena Bonanno, Antonio Rosato, Cristina Geroni, Luigi Quintieri, and Anna Maria Caccuri
|
| 4126-4143 |
|
| miR191 promotes tumorigenesis of human colorectal cancer through targeting C/EBPβ |
|
https://doi.org/10.18632/oncotarget.2864
Xiao-Fei Zhang, Ke-ke Li, Lu Gao, Shang-Ze Li, Ke Chen, Jun-Bin Zhang, Di Wang, Rong-Fu Tu, Jin-Xiang Zhang, Kai-Xiong Tao, Guobin Wang, and Xiao-Dong Zhang
|
| 4144-4158 |
|
| Simultaneous inhibition of deubiquitinating enzymes DUBs and autophagy synergistically kills breast cancer cells |
|
https://doi.org/10.18632/oncotarget.2904
Rachel Isaksson Vogel, Kathleen Coughlin, Alessandra Scotti, Yoshie Iizuka, Ravi Anchoori, Richard B.S. Roden, Mauro Marastoni, and Martina Bazzaro
|
| 4159-4170 |
|
| SKI2162 an inhibitor of the TGFβ type I receptor ALK5 inhibits radiationinduced fibrosis in mice |
|
https://doi.org/10.18632/oncotarget.2878
Jin-hong Park, Seung-Hee Ryu, Eun Kyung Choi, Seung Do Anh, Euisun Park, Kyung-Chul Choi, and Sang-wook Lee
|
| 4171-4179 |
|
| Stagespecific prognostic biomarkers in melanoma |
|
https://doi.org/10.18632/oncotarget.2907
Yabin Cheng, Jing Lu, Guangdi Chen, Gholamreza Safaee Ardekani, Anand Rotte, Magdalena Martinka, Xuezhu Xu, Kevin J McElwee, Guohong Zhang, and Youwen Zhou
|
| 4180-4189 |
|
| Accumulation of FOXP3+Tcells in the tumor microenvironment is associated with an epithelialmesenchymaltransitiontype tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.2775
Martin Wartenberg, Inti Zlobec, Aurel Perren, Viktor Hendrik Koelzer, Beat Gloor, Alessandro Lugli, and Eva Karamitopoulou
|
| 4190-4201 |
|
| RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel |
|
https://doi.org/10.18632/oncotarget.2866
Jing Guo, Yage Yang, Yunsheng Yang, Enqiang Linghu, Qimin Zhan, Malcolm V. Brock, James G. Herman, Bingyong Zhang, and Mingzhou Guo
|
| 4202-4213 |
|
| Glycolytic metabolism influences global chromatin structure |
|
https://doi.org/10.18632/oncotarget.2929
Xue-Song Liu, John B. LIttle, and Zhi-Min Yuan
|
| 4214-4225 |
|
| Farnesoid X receptor associates with βcatenin and inhibits its activity in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.2899
Xijun Liu, Xingwang Zhang, Lingling Ji, Jianxin Gu, Meiling Zhou, and She Chen
|
| 4226-4238 |
|
| WISP-1, a novel angiogenic regulator of the CCN family, promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression |
|
https://doi.org/10.18632/oncotarget.2978
Jing-Yuan Chuang, Po-Chun Chen, Ching-Wen Tsao, An-Chen Chang, Ming-Yu Lein, Ching-Chia Lin, Shih-Wei Wang, Chiao-Wen Lin, and Chih-Hsin Tang
|
| 4239-4252 |
|
| Mucin1 shifts Smad3 signaling from the tumorsuppressive pSmad3C/p21WAF1 pathway to the oncogenic pSmad3L/cMyc pathway by activating JNK in human hepatocellular carcinoma cells |
|
https://doi.org/10.18632/oncotarget.2973
Qiongshu Li, Guomu Liu, Hongyan Yuan, Juan Wang, Yingying Guo, Tanxiu Chen, Ruiping Zhai, Dan Shao, Weihua Ni, and Guixiang Tai
|
| 4253-4265 |
|
| Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth |
|
https://doi.org/10.18632/oncotarget.2887
Guillermo N. Armaiz-Pena, Vianey Gonzalez-Villasana, Archana S. Nagaraja, Cristian Rodriguez-Aguayo, Nouara C. Sadaoui, Rebecca L. Stone, Koji Matsuo, Heather J. Dalton, Rebecca A. Previs, Nicholas B. Jennings, Piotr Dorniak, Jean M. Hansen, Jesusa M. G. Arevalo, Steve W. Cole, Susan K. Lutgendorf, Anil K. Sood, and Gabriel Lopez-Berestein
|
| 4266-4273 |
|
| Identification of PAM4 clivatuzumabreactive epitope on MUC5AC: A promising biomarker and therapeutic target for pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.2760
Donglin Liu, Chien-Hsing Chang, David V. Gold, and David M. Goldenberg
|
| 4274-4285 |
|
| Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2 |
|
https://doi.org/10.18632/oncotarget.3006
Yan Luo, Lei Liu, Yang Wu, Karnika Singh, Bing Su, Nan Zhang, Xiaowei Liu, Yangmei Shen, and Shile Huang
|
| 4286-4298 |
|
| PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects |
|
https://doi.org/10.18632/oncotarget.3012
Raúl Rincón, Ion Cristóbal, Sandra Zazo, Oriol ArpÃ, Silvia Menéndez, Rebeca Manso, Ana Lluch, Pilar Eroles, Ana Rovira, Joan Albanell, Jesús GarcÃa-Foncillas, Juan Madoz-Gúrpide, and Federico Rojo
|
| 4299-4314 |
|
| eIF4E and eIF4GI have distinct and differential imprints on multiple myeloma's proteome and signaling |
|
https://doi.org/10.18632/oncotarget.3008
Oshrat Attar-Schneider, Metsada Pasmanik-Chor, Shelly Tartakover-Matalon, Liat Drucker, and Michael Lishner
|
| 4315-4329 |
|
| Nuclearencoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of highgrade gliomas |
|
https://doi.org/10.18632/oncotarget.3015
Claudia R Oliva, Tahireh Markert, G. Yancey Gillespie, and Corinne E Griguer
|
| 4330-4344 |
|
| GATA1 induces epithelialmesenchymal transition in breast cancer cells through PAK5 oncogenic signaling |
|
https://doi.org/10.18632/oncotarget.2999
Yang Li, Qiang Ke, Yangguang Shao, Ge Zhu, Yanshu Li, Nanxi Geng, Feng Jin, and Feng Li
|
| 4345-4356 |
|
| Inhibition of ERK1/2 downregulates the Hippo/YAP signaling pathway in human NSCLC cells |
|
https://doi.org/10.18632/oncotarget.2974
Bin You, Yi-Lin Yang, Zhidong Xu, Yuyuan Dai, Shu Liu, Jian-Hua Mao, Osamu Tetsu, Hui Li, David M. Jablons, and Liang You
|
| 4357-4368 |
|
| CCAAT/enhancer binding protein β induces motility and invasion of glioblastoma cells through transcriptional regulation of the calcium binding protein S100A4 |
|
https://doi.org/10.18632/oncotarget.2976
Diana Aguilar-Morante, Jose A. Morales-Garcia, Angel Santos, and Ana Perez-Castillo
|
| 4369-4384 |
|
| Progression of naive intraepithelial neoplasia genome to aggressive squamous cell carcinoma genome of uterine cervix |
|
https://doi.org/10.18632/oncotarget.2981
Seung-Hyun Jung, Youn Jin Choi, Min Sung Kim, In-Pyo Baek, Sung Hak Lee, Ah Won Lee, Soo Young Hur, Tae-Min Kim, Sug Hyung Lee, and Yeun-Jun Chung
|
| 4385-4393 |
|
| IL32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU1 |
|
https://doi.org/10.18632/oncotarget.3013
Man Sub Kim, Jeong-Woo Kang, Yun Sun Park, Dong Hun Lee, Yesol Bak, Taeho Kwon, and Do-Young Yoon
|
| 4394-4405 |
|
| HIF2α mediates hypoxiainduced LIF expression in human colorectal cancer cells |
|
https://doi.org/10.18632/oncotarget.3017
Lihua Wu, Haiyang Yu, Yuhan Zhao, Cen Zhang, Jiabei Wang, Xuetian Yue, Qifeng Yang, and Wenwei Hu
|
| 4406-4417 |
|
| GHSR DNA hypermethylation is a common epigenetic alteration of high diagnostic value in a broad spectrum of cancers |
|
https://doi.org/10.18632/oncotarget.2759
Evgeny A. Moskalev, Pouria Jandaghi, Mahdi Fallah, Mehdi Manoochehri, Sandeep K. Botla, Oleg V. Kolychev, Evgeny A. Nikitin, Vladymyr V. Bubnov, M. von Knebel Doeberitz, Oliver Strobel, Thilo Hackert, Markus W. Büchler, Nathalia Giese, Andrea Bauer, Thomas Muley, Arne Warth, Peter Schirmacher, Florian Haller, Jörg D. Hoheisel, and Yasser Riazalhosseini
|
| 4418-4427 |
|
| Immunological response and overall survival in a subset of advanced renal cell carcinoma patients from a randomized phase 2/3 study of naptumomab estafenatox plus IFNα versus IFNα |
|
https://doi.org/10.18632/oncotarget.2922
Eyad Elkord, Deborah J. Burt, Anette Sundstedt, Örjan Nordle, Gunnar Hedlund, and Robert E. Hawkins
|
| 4428-4439 |
|
| Hepatocellular carcinoma in a large medical center of China over a 10year period: evolving therapeutic option and improving survival |
|
https://doi.org/10.18632/oncotarget.2913
Qianqian Zhu, Na Li, Xiaoyan Zeng, Qunying Han, Fang Li, Cuiling Yang, Yi Lv, Zhihua Zhou, and Zhengwen Liu
|
| 4440-4450 |
|
| RACK1 is a candidate gene associated with the prognosis of patients with early stage nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.2865
Yi-Young Choi, Shin Yup Lee, Won Kee Lee, Hyo-Sung Jeon, Eung Bae Lee, Hyun Cheol Lee, Jin Eun Choi, Hyo-Gyoung Kang, Eun Jin Lee, Eun Young Bae, Seung Soo Yoo, Jaehee Lee, Seung Ick Cha, Chang Ho Kim, In-San Kim, Myung Hoon Lee, Young Tae Kim, Sanghoon Jheon, and Jae Yong Park
|
| 4451-4466 |
|
| Immunological data from cancer patients treated with Ad5/3 E2F Δ24 GMCSF suggests utility for tumor immunotherapy |
|
https://doi.org/10.18632/oncotarget.2901
Otto Hemminki, Suvi Parviainen, Juuso Juhila, Riku Turkki, Nina Linder, Johan Lundin, Matti Kankainen, Ari Ristimäki, Anniina Koski, Ilkka Liikanen, Minna Oksanen, Dirk M. Nettelbeck, Kalevi Kairemo, Kaarina Partanen, Timo Joensuu, Anna Kanerva, and Akseli Hemminki
|
| 4467-4481 |
|
| Poor survival is associated with the methylated degree of Zincfinger protein 545 ZNF545 DNA promoter in gastric cancer |
|
https://doi.org/10.18632/oncotarget.2916
Jingyu Deng, Han Liang, Guoguang Ying, Qiuping Dong, Rupeng Zhang, Jun Yu, Daiming Fan, and Xishan Hao
|
| 4482-4495 |
|
| Safety and biodistribution of 111Inamatuximab in patients with mesothelin expressing cancers using single photon emission computed tomographycomputed tomography SPECTCT imaging |
|
https://doi.org/10.18632/oncotarget.2883
Liza Lindenberg, Anish Thomas, Stephen Adler, Esther Mena, Karen Kurdziel, Julia Maltzman, Bruce Wallin, Kimberly Hoffman, Ira Pastan, Chang Hum Paik, Peter Choyke, and Raffit Hassan
|
| 4496-4504 |
|
| Circulation long noncoding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.2934
Junwei Tang, Runqiu Jiang, Lei Deng, Xudong Zhang, Ke Wang, and Beicheng Sun
|
| 4505-4515 |
|
| GOT1/AST1 expression status as a prognostic biomarker in pancreatic ductal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.2799
Fenja M Feld, Philipp D Nagel, Stephanie E Weissinger, Claudia Welke, Albrecht Stenzinger, Peter Möller, and Jochen K Lennerz
|
| 4516-4526 |
|
| A Phase I trial of high dose gefitinib for patients with leptomeningeal metastases from nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.2886
David M. Jackman, Leigh Anne Cioffredi, Lorraine Jacobs, Farhana Sharmeen, Linda K. Morse, Joan Lucca, Scott R. Plotkin, Paul J. Marcoux, Michael S. Rabin, Thomas J. Lynch, Bruce E. Johnson, and Santosh Kesari
|
| 4527-4536 |
|
| Identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.3005
Jeff P. Bruce, Angela B.Y. Hui, Wei Shi, Bayardo Perez-Ordonez, Ilan Weinreb, Wei Xu, Benjamin Haibe-Kains, Daryl M. Waggott, Paul C. Boutros, Brian O’Sullivan, John Waldron, Shao Hui Huang, Eric X. Chen, Ralph Gilbert, and Fei-Fei Liu
|
| 4537-4550 |
